ACLARION, INC. Total Liabilities and Equity
ACLARION, INC. (ACON) had Total Liabilities and Equity of $18.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-06
- 2026-06-30: Liabilities and Equity $18.04M.
- 2026-03-31: Liabilities and Equity $20.64M.
- 2025-12-31: Liabilities and Equity $13.67M.
- 2025-09-30: Liabilities and Equity $13.20M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $18.04M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $20.64M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $13.67M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $13.20M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $14.75M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $16.48M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.12M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $3.19M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $3.09M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $3.73M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.46M 10-K · filed 2025-04-09 | |
| 2023-09-30 | $1.54M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.00M 10-Q · filed 2023-08-25 | |
| 2023-03-31 | $1.86M 10-Q · filed 2023-07-03 | |
| 2022-12-31 | $2.91M 10-K · filed 2024-03-28 | $3.21M 10-K · filed 2023-02-27 |
| 2022-09-30 | $4.10M 10-K/A · filed 2023-06-12 | |
| 2022-06-30 | $5.62M 10-Q · filed 2023-08-25 | |
| 2022-03-31 | $1.81M 10-Q · filed 2022-06-06 | |
| 2021-12-31 | $1.89M 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |